Serious Infectious Complications After Rituximab Therapy in Patients With Autoimmunity: Is This the Final Word?
Author:
Affiliation:
1. Department of Infectious Diseases, Cambridge University Hospitals, Cambridge, United Kingdom
2. Department of Clinical Immunology, Cambridge University Hospitals, Cambridge, United Kingdom
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Microbiology (medical)
Link
http://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaa131/33679721/ciaa131.pdf
Reference35 articles.
1. Management of toxicities from immunotherapy: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Haanen;Ann Oncol,2018
2. Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis;Lanini;BMC Med,2011
3. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) consensus document on the safety of targeted and biological therapies: an infectious diseases perspective (agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52);Mikulska;Clin Microbiol Infect,2018
4. The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases;Cooper;Br J Haematol,2010
5. Diagnostic and therapeutic considerations in patients with hypogammaglobulinemia after rituximab therapy;Kado;Curr Opin Rheumatol,2017
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Infective endocarditis complicating rituximab in a lupus patient with lupus nephritis and dilated cardiomyopathy: case report and review of literature;The Egyptian Journal of Internal Medicine;2023-02-22
2. Use of tafenoquine to treat a patient with relapsing babesiosis with clinical and molecular evidence of resistance to azithromycin and atovaquone;IDCases;2022
3. Mechanism of Action and Efficacy of Immunosupressors in Lupus Nephritis;International Journal of Nephrology and Renovascular Disease;2021-12
4. Peripheral B Cell Deficiency and Predisposition to Viral Infections: The Paradigm of Immune Deficiencies;Frontiers in Immunology;2021-08-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3